跳至主要内容
临床试验/NCT05446493
NCT05446493已完成4 期

Assessment of Serum YKL-40 Level and Platelets Indices Among Patients With Diabetic Erectile Dysfunction

Aswan University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2019年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
60
试验地点
1
主要终点
Serum YKL-40 and platelets indices in erectile dysfunction

研究概览

简要总结

The aim of this current study is to estimate serum level of YKL-40, serum total testosterone and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil 5mg for 3 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
30 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Diabetic patients with ED.

排除标准

  • Patients with history of pelvic trauma.
  • Patients with major pelvic surgical intervention.
  • Patients with hypogonadism and hyperprolactinemia.
  • Patients with chronic liver disease.
  • Patients with cardio vascular system diseases.
  • History of chronic intake of central nervous system, anti androgen drugs or other drugs as Tramadol.
  • Smokers patients.
  • Patients with non-vasculogenic Erectile dysfunction.

研究组 & 干预措施

Tadalafil group

Active Comparator

Each patient will be treated by tadalafil 5mg daily for 3months

干预措施: Tadalafil 5mg (Drug)

结局指标

主要结局

Serum YKL-40 and platelets indices in erectile dysfunction

时间窗: 3 months

Measurement of YKL-40 and platelets indices in diabetic patients with erectile dysfunction treated by daily tadalafil.

次要结局

  • Effect of tadalafil on Erectile dysfucntion patients(3 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Amer Ahmed Abdellatif

Assistant lecturer

Aswan University

研究点 (1)

Loading locations...

相似试验

Serum YKL-40 Level and Platelets Indices Among... | 临床试验